Alexion Pharm Inc (ALXN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
03-1997 | 12-1996 | 09-1996 | 06-1996 | 03-1996 | |
Assets | |||||
Current Assets | |||||
Cash & Cash Equivalents | 8,635 | 7,288 | 9,491 | 9,491 | 19,078 |
Marketable Securities | 6,762 | 9,207 | 9,107 | 9,107 | 628 |
Other current assets | 232 | 397 | 467 | 467 | 391 |
TOTAL | $15,629 | $16,892 | $19,065 | $19,065 | $20,097 |
Non-Current Assets | |||||
PPE Net | 2,985 | 2,754 | 2,550 | 2,550 | 2,445 |
Other Non-Current Assets | 741 | 769 | 797 | 797 | 0 |
TOTAL | $3,726 | $3,523 | $3,347 | $3,347 | $2,445 |
Total Assets | $17,103 | $18,293 | $20,454 | $20,454 | $21,571 |
Liabilities | |||||
Current Liabilities | |||||
Short Term Debt | 276 | 0 | 322 | 322 | N/A |
Accounts payable and accrued liabilities | 367 | 322 | 281 | 281 | 0 |
Accrued Expenses | 464 | 353 | 401 | 401 | N/A |
Other current liabilities | 131 | 471 | 1,000 | 1,000 | N/A |
TOTAL | $1,259 | $1,464 | $2,032 | $2,032 | $1,389 |
Non-Current Liabilities | |||||
Long Term Debt | 0 | 58 | 128 | 128 | N/A |
TOTAL | $1 | $62 | $136 | $136 | $N/A |
Total Liabilities | $1,260 | $1,526 | $2,168 | $2,168 | $1,389 |
Shareholders' Equity | |||||
Common Shares | 1 | 1 | 1 | 1 | 1 |
Retained earnings | -27,188 | -26,152 | -24,574 | -24,574 | N/A |
Other shareholders' equity | 0 | 0 | 0 | 0 | 19,966 |
TOTAL | $15,843 | $16,767 | $18,286 | $18,286 | $19,967 |
Total Liabilities And Equity | $17,103 | $18,293 | $20,454 | $20,454 | $21,356 |